Summary

Eligibility
for people ages 18 years and up (full criteria)
Healthy Volunteers
healthy people welcome
Location
at San Francisco, California and other locations
Dates
study started
completion around

Description

Summary

ALAMO is a prospective, multi-center, perspective, registry of patients receiving LungCare™ (AlloSure®-Lung, AlloMap Lung, and HistoMap) for surveillance post-transplant. This study aims to evaluate the diagnostic performance characteristics of AlloSure Lung (dd-cfDNA) to detect a spectrum of rejection (ACR, AMR) and allograft infection (Bacterial, Viral, Fungal, Mycobacterial, Parasitic).

Details

Keywords

Lung Transplant Infection, Lung Transplant; Complications, Lung Transplant Failure and Rejection

Eligibility

Locations

  • University of California (UCSF) School of Medicine in progress, not accepting new patients
    San Francisco California 94143 United States
  • Cedars Sinai Medical Center accepting new patients
    Los Angeles California 90048 United States
  • St. Joseph's Hospital & Medical Center accepting new patients
    Phoenix Arizona 85013 United States

Details

Status
accepting new patients at some sites,
but this study is not currently recruiting here
Start Date
Completion Date
(estimated)
Sponsor
CareDx
ID
NCT05050955
Study Type
Observational [Patient Registry]
Participants
Expecting 550 study participants
Last Updated